NECTAR LIFESCIENCES
Back to Cashflow Statement
|
NECTAR LIFESCIENCES Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹169 Cr | ₹225 Cr | ₹134 Cr | ₹95 Cr | ₹21 Cr |
What is the latest Cash Flow from Operating Activities ratio of NECTAR LIFESCIENCES ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹169 Cr |
| Mar2024 | ₹225 Cr |
| Mar2023 | ₹134 Cr |
| Mar2022 | ₹95 Cr |
| Mar2021 | ₹21 Cr |
How is Cash Flow from Operating Activities of NECTAR LIFESCIENCES Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹169 Cr | -24.59 | |
| Mar2024 | ₹225 Cr | 68.11 | |
| Mar2023 | ₹134 Cr | 40.68 | |
| Mar2022 | ₹95 Cr | 344.38 | |
| Mar2021 | ₹21 Cr | - | |
Compare Cash Flow from Operating Activities of peers of NECTAR LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NECTAR LIFESCIENCES | ₹206.9 Cr | -0.7% | -2.7% | -24% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,394.0 Cr | -3% | -4.1% | 16.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,312.0 Cr | 0.6% | 17.5% | 41.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,678.0 Cr | 1.7% | -0.6% | 35.5% | Stock Analytics | |
| CIPLA | ₹114,392.0 Cr | -2% | -0.7% | -4.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,740.5 Cr | -1.5% | -3.5% | -2.2% | Stock Analytics | |
NECTAR LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NECTAR LIFESCIENCES | -0.7% |
-2.7% |
-24% |
| SENSEX | -1.4% |
-1% |
-4.6% |
You may also like the below Video Courses